In April 2015, I wrote a piece showing how Warren Buffett might look at Biogen (NASDAQ:BIIB). While the numbers for the biotech pharmaceutical company looked good, I stated at that time, "Based on this methodology, a good entry price would be $282, but given Biogen's current price of $430, it will be awhile before an opportunity should present itself. The current
MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney
Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm
BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)
BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
